Literature DB >> 15995521

Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation.

Theresa A Gurney1, David W Eisele, Vivian Weinberg, Ed Shin, Nancy Lee.   

Abstract

OBJECTIVE: To examine patient characteristics, pathologic features, and treatment outcomes of adenoid cystic carcinoma of the major salivary glands. STUDY
DESIGN: Retrospective review of patients in an academic medical center.
METHOD: Review of medical records regarding demographics, extent of tumor, stage, histologic characteristics, and treatment outcomes of patients treated with surgery and postoperative radiation.
RESULTS: Of the 33 patients, 19 (58%) were male, and 14 (42%) were female. The average age of presentation was 49 (range 22-81) years. Of the 29 patients fully staged at the time of diagnosis, 7 (24%) presented at American Joint Committee on Cancer stage I, 9 (31%) at stage II, 4 (14%) at stage III, and 9 (31%) at stage IV. The cribriform histologic subtype was predominant (64%). The majority originated in the parotid gland (21, 64%), with the remaining originating in either the submandibular gland (10, 30%) or the sublingual gland (2, 6%). Local control was 94% at 5 years and 73% at 10 years. Metastatic control was 82% at 5 years and 63% at 10 years. Four patients failed locally and nine failed distally. Overall survival was 85% at 5 years and 69% at 10 years, with a median of 12.9 years.
CONCLUSION: Surgical excision with postoperative radiation provides a long period of disease-free survival. Patients were more likely to fail with metastases than with local recurrence.

Entities:  

Mesh:

Year:  2005        PMID: 15995521     DOI: 10.1097/01.MLG.0000165381.64157.AD

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  21 in total

1.  Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.

Authors:  Trevor M Feinstein; Stephen Y Lai; Diana Lenzner; William Gooding; Robert L Ferris; Jennifer R Grandis; Eugene N Myers; Jonas T Johnson; Dwight E Heron; Athanassios Argiris
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

2.  [2014: activation of OPS 8-980 "Complex intensive care treatment" by DIMDI].

Authors:  L Engelmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-12-20       Impact factor: 0.840

Review 3.  Review of clinical experience with ion beam radiotherapy.

Authors:  A D Jensen; M W Münter; J Debus
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 4.  NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review.

Authors:  Nolan B Seim; Ramez H W Philips; Lynn Schoenfield; Theodoros N Teknos; James W Rocco; Amit Agrawal; Enver Ozer; Ricardo L Carrau; Stephen Y Kang; Matthew O Old
Journal:  Head Neck Pathol       Date:  2017-03-27

5.  Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.

Authors:  Alexandra D Jensen; Anna V Nikoghosyan; Swantje Ecker; Malte Ellerbrock; Jürgen Debus; Klaus K Herfarth; Marc W Münter
Journal:  Radiat Oncol       Date:  2011-11-02       Impact factor: 3.481

6.  Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Samuel Jang; Priyesh N Patel; Randall J Kimple; Timothy M McCulloch
Journal:  Anticancer Res       Date:  2017-06       Impact factor: 2.480

7.  Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy.

Authors:  Jae Myoung Noh; Yong Chan Ahn; Heerim Nam; Won Park; Chung-Hwan Baek; Young-Ik Son; Han-Sin Jeong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-06-30       Impact factor: 3.372

8.  Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.

Authors:  Alexandra D Jensen; Anna Nikoghosyan; Christine Windemuth-Kieselbach; Jürgen Debus; Marc W Münter
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

9.  Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.

Authors:  Bin Liu; Yoshitsugu Mitani; Xiayu Rao; Mark Zafereo; Jianjun Zhang; Jianhua Zhang; P Andrew Futreal; Guillermina Lozano; Adel K El-Naggar
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

10.  Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer.

Authors:  Yusuke Azami; Yuichiro Hayashi; Tatsuya Nakamura; Kanako Kimura; Hisashi Yamaguchi; Takashi Ono; Kanako Takayama; Katsumi Hirose; Tomonori Yabuuchi; Motohisa Suzuki; Yoshiomi Hatayama; Masato Hareyama; Yasuhiro Kikuchi; Nobukazu Fuwa
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.